PRUDENTIAL FINANCIAL INC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 165 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRUDENTIAL FINANCIAL INC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,411,838
+19.4%
1,282,426
-12.3%
0.01%
+14.3%
Q2 2023$4,530,731
+172.3%
1,461,526
+22.1%
0.01%
+133.3%
Q1 2023$1,663,783
-9.3%
1,196,966
+29.9%
0.00%0.0%
Q4 2022$1,834,215
+13.3%
921,716
+15.0%
0.00%0.0%
Q3 2022$1,619,000
+52.3%
801,466
+139.8%
0.00%
+50.0%
Q2 2022$1,063,000
-29.7%
334,166
-7.9%
0.00%0.0%
Q1 2022$1,513,000
-32.7%
362,866
-22.7%
0.00%
-33.3%
Q4 2021$2,248,000
-49.7%
469,426
-43.9%
0.00%
-50.0%
Q3 2021$4,468,000
-19.5%
836,659
-22.8%
0.01%
-25.0%
Q2 2021$5,548,000
-36.5%
1,083,752
-16.6%
0.01%
-38.5%
Q1 2021$8,743,000
+39.3%
1,299,114
-5.4%
0.01%
+18.2%
Q4 2020$6,275,000
+17.7%
1,373,063
-0.1%
0.01%
+10.0%
Q3 2020$5,330,000
-7.1%
1,373,863
+14.0%
0.01%
-9.1%
Q2 2020$5,737,000
+68.9%
1,205,234
+23.5%
0.01%
+57.1%
Q1 2020$3,397,000
-23.0%
976,119
+6.6%
0.01%0.0%
Q4 2019$4,414,000
+65.4%
915,880
-0.5%
0.01%
+75.0%
Q3 2019$2,669,000
+2220.9%
920,588
+5644.7%
0.00%
Q2 2019$115,000
-54.2%
16,025
-9.4%
0.00%
Q1 2019$251,000
+4.1%
17,693
-0.5%
0.00%
Q4 2018$241,000
-37.2%
17,790
+2.6%
0.00%
-100.0%
Q3 2018$384,000
+29.3%
17,344
-4.2%
0.00%
Q2 2018$297,00018,1000.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders